Medical Writing, Consultant California-San Francisco
7/10/2014 3:54 PM

Preferred Degree: Unspecified Job Type: Part Time Experience (Years): 4-6 Job Category: Clinical Development/Affairs Why Join Us? Ultragenyx is a clinical stage biotechnology company committed to bringing novel products for the treatment of rare and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. We are laun  ...View Job
Director / Senior Director, Clinical Affairs MD California-San Francisco
7/10/2014 3:51 PM

Preferred Degree: Doctorate Job Type: Full Time Experience (Years): 8-10 Job Category: Clinical Development/Affairs Why Join Us Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rate and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. We   ...View Job
Manager, Drug Safety & Pharmacovigilance California-San Francisco
7/8/2014 10:42 AM

Why Join Us Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. We are launching five Phase 2 clinical trials and with another preclinical trial in the pipeline. Where possible, our strategy is to acquire and retain global co  ...View Job
Director, Regulatory Affairs California-San Francisco
7/8/2014 10:39 AM

Why Join Us Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rate and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. We are launching five Phase 2 clinical trials and with another preclinical trial in the pipeline. Where possible, our strategy is to acquire and retain global co  ...View Job
Director, Pharmacology & Toxicology California-San Francisco
7/8/2014 10:37 AM

Why Join Us Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. We are launching five Phase 2 clinical trials and with another preclinical trial in the pipeline. Where possible, our strategy is to acquire and retain global co  ...View Job